Development and Exploitation of New Synthetic Strategies for Tropolones
Development and Exploitation of New Synthetic Strategies for Tropolones
批准号:
10394902
负责人:
Ryan Murelli
金额:
$39.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-01 至 2024-04-30
关键词:
AcidsAirAlder plantAnti-Inflammatory AgentsAntimalarialsAntiviral AgentsArchitectureBindingBiologyC-terminalChemicalsChemistryColchicineDevelopmentEligibility DeterminationEnvironmentFDA approvedFundingFunding MechanismsFunding OpportunitiesFutureGenerationsGoalsGrantHealthHerpesviridaeHumanHuman Herpesvirus 8KnowledgeLearningLegal patentLiteratureLyticMalariaMedicalMedicineMethodsMissionModernizationMolecularNatural ProductsOrganic ChemistryPharmaceutical ChemistryPharmaceutical PreparationsProceduresProcessPropertyPublic HealthPyransPyronesResearchResourcesRouteScienceScientistSynthesis ChemistryTechniquesTestingTextbooksTherapeuticTropoloneanti-cancerantiviral drug developmentbasebioactive natural productscareercatalystchemical reactioncycloadditiondesignimprovedinhibitorinnovationinterestmetalloenzymenoveloxidationprogramsquinone methidescaffoldsmall moleculetoolundergraduate studentvirtual
中文摘要
项目概要和摘要
肌钙蛋白是天然存在的芳香族7元环,尽管其在化学上是众所周知的,
在药物化学研究中,以及更广泛地在功能性药物的开发中,
常规小分子。这在很大程度上与其合成相关的挑战有关,并且限制了
他们的独特性质如何在分子设计中发挥作用,这一点值得赞赏。更广泛的Ob-
当前提案的目标是开发与肌钙蛋白相关的新工具和知识,重点是
在生物医学上的应用目的1将开发广泛的疱疹病毒抗病毒活性的
α-羟基酚酮在卡波西肉瘤相关疱疹病毒(KSHV)的“踢杀”策略中。
具体而言,我们将优化α-羟基环庚三烯酚酮作为KSHV ORF 29的C-末端结构域的抑制剂。
作为这一目标的一部分,我们还将对一种新发现的KSHV裂解激活剂进行优化研究,
与KSHV PAN ENE结合。目的2将探索氧化吡喃鎓环加成/开环方法,
4-羟基托酚酮。这一目标将推进与3-羟基-4-吡喃酮基氧化吡喃鎓相关的知识
环加成反应,也提供了一个新的和有效的途径,吡喃稠环酚酮,这是一个
存在于各种生物活性天然产物中的结构特征,包括有效的抗癌分子
碧萝芷。最后,aim 3将探索环膨胀/空气氧化方法,
其将用于靶向合成诸如抗疟疾天然产物的分子
毛孢糖酸这一目标的核心将重新审视一个非常有效的方法来产生tropolones
半个世纪前的研究。我们将通过利用高效的空气氧化来改进程序-
我们实验室最近发现的反应过程,并研究了底物和催化剂对区域选择性的控制
芳烃环丙烷化反应。这些目标的完成将突出生物医学的潜力
作为药物片段,完善我们实验室以前开发的合成策略,建立新的
环庚三烯酚酮的合成方法,以及与相关化学反应相关的先进知识,
例如氧化吡喃鎓环加成和环丙烷化化学。
英文摘要
Project Summary and Abstract
Troponoids are naturally occurring aromatic 7-membered rings that, despite being well-known to chem-
ists, are highly underexploited in medicinal chemistry studies, and more broadly in the development of func-
tional small-molecules. This can be largely tied to the challenges associated with their synthesis, and a lim-
ited appreciation for how their unique properties could be leveraged in molecular design. The broader ob-
jective of the current proposal is to develop new tools and knowledge related to troponoids, with an empha-
sis on their utility biomedically. Aim 1 will exploit the broad herpesvirus antiviral activity of
α-hydroxytropolones in a `kick-and-kill' strategy for Kaposi's sarcoma-associated herpesvirus (KSHV).
Specifically, we will optimize α-hydroxytropolones as inhibitors of the C-terminal domain of KSHV ORF29.
As part of this aim, we will also carry out optimization studies on a newly identified KSHV lytic activator that
binds to KSHV PAN ENE. Aim 2 will explore an oxidopyrylium cycloaddition/ring-opening approach to
4-hydroxytropolones. This aim will advance knowledge related to 3-hydroxy-4-pyrone-based oxidopyrylium
cycloaddition chemistry, and also provide a new and efficient route to pyran-fused tropolones, which is a
structural feature that exists in various bioactive natural products, including the potent anti-cancer molecule
pycnidione. Finally, aim 3 will explore a Büchner ring-expansion/ air oxidation approach to tropolones,
which will be used in target-oriented synthesis towards molecules such as the antimalarial natural product
puberulonic acid. This aim at its core will revisit an exceptionally efficient method to generate tropolones
that was studied over half a century ago. We will improve the procedure by leveraging an efficient air oxida-
tion process recently discovered in our lab, and study substrate and catalyst control on the regioselectivity
of arene cyclopropanation. The completion of these aims are expected to highlight the biomedical potential
of troponoid as a drug fragment, refine synthetic strategies previously developed in our lab, establish new
methods for tropolone synthesis, and advance knowledge related to the associated chemical reactions,
such oxidopyrylium cycloaddition and cyclopropanation chemistry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and Exploitation of New Synthetic Strategies for Tropolones
-
批准号:10192742
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2015
-
负责人:Ryan Murelli
-
依托单位:
Biological Studies of alpha-Hydroxytropolones
-
批准号:9271213
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2015
-
负责人:Ryan Murelli
-
依托单位:
Biological Studies of alpha-Hydroxytropolones
-
批准号:8854644
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2015
-
负责人:Ryan Murelli
-
依托单位:
Development and Exploitation of New Synthetic Strategies for Tropolones
-
批准号:10614944
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2015
-
负责人:Ryan Murelli
-
依托单位:
Biological Studies of alpha-Hydroxytropolones
-
批准号:9059733
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2015
-
负责人:Ryan Murelli
-
依托单位:
Synthetic and biological studies of understudied anti-tubercular natural products
-
批准号:8588341
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2012
-
负责人:Ryan Murelli
-
依托单位:
Synthetic and biological studies of understudied anti-tubercular natural products
-
批准号:8436229
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2012
-
负责人:Ryan Murelli
-
依托单位:
Synthetic and biological studies of understudied anti-tubercular natural products
-
批准号:8214046
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2012
-
负责人:Ryan Murelli
-
依托单位:
国内基金
海外基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
-
批准号:51976048
-
项目类别:面上项目
-
资助金额:61.0万元
-
批准年份:2019
-
负责人:邱朋华
-
依托单位: